Development and validation of a prognostic and predictive 32-gene signature for gastric cancer
2022 · Nature Communications · 109 citations
https://doi.org/10.1038/s41467-022-28437-y
H
Hyo Song Kim
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
298
Papers
5.2K
Citations
40
h-index
118
i10-index
Hyo Song Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Sarcoma Diagnosis and Treatment & Colorectal Cancer Treatments and Studies. The author has an h-index of 40, co-authored 254 publications.
ORCID: 0000-0002-0625-9828Papers by this author
worksEfficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series
2015 · BMC Cancer · 75 citations
https://doi.org/10.1186/s12885-015-1160-x
Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study
2010 · BMC Cancer · 64 citations
https://doi.org/10.1186/1471-2407-10-167
First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors
2022 · Investigational New Drugs · 54 citations
https://doi.org/10.1007/s10637-022-01277-9
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer
2022 · Nature Communications · 51 citations
https://doi.org/10.1038/s41467-022-33267-z
Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy
2009 · BMC Cancer · 48 citations
https://doi.org/10.1186/1471-2407-9-205
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat